NDC 69097-315

Lamivudine and Zidovudine

Lamivudine And Zidovudine

Lamivudine and Zidovudine is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Lamivudine; Zidovudine.

Product ID69097-315_c360bd83-8e40-4dcf-9d91-1949a99e775c
NDC69097-315
Product TypeHuman Prescription Drug
Proprietary NameLamivudine and Zidovudine
Generic NameLamivudine And Zidovudine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2018-09-07
Marketing CategoryANDA / ANDA
Application NumberANDA077411
Labeler NameCipla USA Inc.
Substance NameLAMIVUDINE; ZIDOVUDINE
Active Ingredient Strength150 mg/1; mg/1
Pharm ClassesHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 69097-315-03

60 TABLET, FILM COATED in 1 BOTTLE (69097-315-03)
Marketing Start Date2018-09-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69097-315-21 [69097031521]

Lamivudine and Zidovudine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA077411
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-09-07
Inactivation Date2020-01-31

NDC 69097-315-02 [69097031502]

Lamivudine and Zidovudine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA077411
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-09-07
Inactivation Date2020-01-31

NDC 69097-315-03 [69097031503]

Lamivudine and Zidovudine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA077411
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-09-07
Inactivation Date2020-01-31

NDC 69097-315-15 [69097031515]

Lamivudine and Zidovudine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA077411
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-09-07
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
LAMIVUDINE150 mg/1

OpenFDA Data

SPL SET ID:ed84496b-ef83-4af7-a24b-7d9d2d65cf84
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 200082

    • Pharmacological Class

    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]

    NDC Crossover Matching brand name "Lamivudine and Zidovudine" or generic name "Lamivudine And Zidovudine"

    NDCBrand NameGeneric Name
    21695-996Lamivudine and ZidovudineLamivudine and Zidovudine
    31722-506LAMIVUDINE and ZIDOVUDINELAMIVUDINE and ZIDOVUDINE
    31722-739Lamivudine and ZidovudineLamivudine and Zidovudine
    33342-003Lamivudine and ZidovudineLamivudine and Zidovudine
    42291-363Lamivudine and ZidovudineLamivudine and Zidovudine
    43063-346Lamivudine and ZidovudineLamivudine and Zidovudine
    43063-900lamiVUDine and ZIDOVUDINElamiVUDine and ZIDOVUDINE
    50090-3920LAMIVUDINE and ZIDOVUDINELAMIVUDINE and ZIDOVUDINE
    50268-456LAMIVUDINE and ZIDOVUDINELAMIVUDINE and ZIDOVUDINE
    50436-0597Lamivudine and ZidovudineLamivudine and Zidovudine
    54741-102Lamivudine and Zidovudinelamivudine and zidovudine
    55700-096Lamivudine and ZidovudineLamivudine and Zidovudine
    57297-284LAMIVUDINE AND ZIDOVUDINELAMIVUDINE AND ZIDOVUDINE
    63629-4872Lamivudine and ZidovudineLamivudine and Zidovudine
    64380-707Lamivudine and ZidovudineLamivudine and Zidovudine
    65862-036Lamivudine and ZidovudineLamivudine and Zidovudine
    65862-597Lamivudine and ZidovudineLamivudine and Zidovudine
    68071-3311Lamivudine and ZidovudineLamivudine and Zidovudine
    68071-4450LAMIVUDINE and ZIDOVUDINELAMIVUDINE and ZIDOVUDINE
    68084-416Lamivudine and ZidovudineLamivudine and Zidovudine
    68180-284LAMIVUDINE AND ZIDOVUDINELAMIVUDINE AND ZIDOVUDINE
    68788-6394Lamivudine and ZidovudineLamivudine and Zidovudine
    68788-7298LAMIVUDINE and ZIDOVUDINELAMIVUDINE and ZIDOVUDINE
    69097-315Lamivudine and ZidovudineLamivudine and Zidovudine
    70518-0697Lamivudine and ZidovudineLamivudine and Zidovudine
    71335-0141Lamivudine and ZidovudineLamivudine and Zidovudine
    71335-0639LAMIVUDINE and ZIDOVUDINELAMIVUDINE and ZIDOVUDINE
    76519-1005Lamivudine and ZidovudineLamivudine and Zidovudine
    76282-115Lamivudine and ZidovudineLamivudine and Zidovudine
    72865-144LAMIVUDINE AND ZIDOVUDINELAMIVUDINE AND ZIDOVUDINE
    21695-846COMBIVIRlamivudine and zidovudine
    49702-202COMBIVIRlamivudine and zidovudine
    50090-0610COMBIVIRlamivudine and zidovudine
    52959-546COMBIVIRlamivudine and zidovudine
    53808-0895COMBIVIRlamivudine and zidovudine
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.